Business
Biotech Scores Again With LSD In Anxiety; Stock Rises - Investor's Business Daily

What the report says
Definium Therapeutics unveiled the second of two positive Phase 3 studies.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Equity Group roadshow seeks to unlock cross-border trade and investmentNile Post
Equity trade mission puts Uganda’s investment potential in spotlightNile Post
Ibanda Traders Report Slow Scholastic Sales as Third Term OpensNile Post